Mapping the brain: How cell types and location influence Parkinson’s disease

Targeted BRAF-MEK inhibition resulted in a response in nearly all patients with untreated BRAF V600E–mutated papillary craniopharyngioma, according to results from a small phase II

Astel­las, which is ready­ing a Su­per Bowl ad for its hot flash menopause treat­ment Veozah, sig­nif­i­cant­ly cut the drug’s sales fore­cast for the year, cit­ing